U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C16H20N4O2
Molecular Weight 300.3556
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BIA-10-2474

SMILES

CN(C1CCCCC1)C(=O)N2C=NC(=C2)C3=C[N+]([O-])=CC=C3

InChI

InChIKey=DOWVMJFBDGWVML-UHFFFAOYSA-N
InChI=1S/C16H20N4O2/c1-18(14-7-3-2-4-8-14)16(21)19-11-15(17-12-19)13-6-5-9-20(22)10-13/h5-6,9-12,14H,2-4,7-8H2,1H3

HIDE SMILES / InChI

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
4.9 nM [IC50]
PubMed

PubMed

TitleDatePubMed
Lessons from the fatal French study BIA-10-2474.
2016 May 18
Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474.
2017 Jun 9
Inhibition of fatty acid amide hydrolase by BIA 10-2474 in rat brain.
2017 Nov
Name Type Language
BIA-10-2474
Common Name English
BIA-102474-101
Code English
BIA 10-2474
Code English
1H-IMIDAZOLE-1-CARBOXAMIDE, N-CYCLOHEXYL-N-METHYL-4-(1-OXIDO-3-PYRIDINYL)-
Systematic Name English
Code System Code Type Description
SMS_ID
300000041440
Created by admin on Sat Dec 16 10:14:52 GMT 2023 , Edited by admin on Sat Dec 16 10:14:52 GMT 2023
PRIMARY
EPA CompTox
DTXSID901009325
Created by admin on Sat Dec 16 10:14:52 GMT 2023 , Edited by admin on Sat Dec 16 10:14:52 GMT 2023
PRIMARY
PUBCHEM
46831476
Created by admin on Sat Dec 16 10:14:52 GMT 2023 , Edited by admin on Sat Dec 16 10:14:52 GMT 2023
PRIMARY
CAS
1233855-46-3
Created by admin on Sat Dec 16 10:14:52 GMT 2023 , Edited by admin on Sat Dec 16 10:14:52 GMT 2023
PRIMARY
WIKIPEDIA
BIA 10-2474
Created by admin on Sat Dec 16 10:14:52 GMT 2023 , Edited by admin on Sat Dec 16 10:14:52 GMT 2023
PRIMARY
FDA UNII
5AP1ZW859M
Created by admin on Sat Dec 16 10:14:52 GMT 2023 , Edited by admin on Sat Dec 16 10:14:52 GMT 2023
PRIMARY